J&J gets out of diagnostics

Share this article:

Johnson & Johnson is offloading its Ortho Diagnostics business for $4 billion. The company announced Monday that it accepted the Carlyle Group's January offer to take on the business, which includes in-vitro diagnostic products.

Bloomberg reports that Carlyle expects to run the unit as a standalone business, and that the transaction relieves J&J of its only diagnostics division.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.